Tablets & Capsules

TC0614SB

Issue link: https://www.e-digitaleditions.com/i/331259

Contents of this Issue

Navigation

Page 7 of 107

6 June 2014 Tablets & Capsules Solid Dosage SourceBook With over 40 years' experience Almac provide a comprehensive range of services, from formulation development through to commercial supply. Our UK and US facilities are quality led and operate to the highest levels of cGMP. Global regulatory authority approvals include FDA, MHRA, ANVISA and PMDA. Pharmaceutical Development Our team of highly skilled scientists develop clinical candidates into optimum formulations and manufacture drug products for all phases of clinical trial supply. Key services include: • Non GMP formulation development • Early stage development (FIH studies) • QbD and DOE studies • Clinical batch manufacture • Process optimisation & scale-up • Analytical development Our dedicated facilities are fully temperature and RH controlled with containment technology in place to process potent compounds. Commercial Launch Over the past 5 years we have assisted in the successful launch of more than 20 orphan/niche drugs into the EU marketplace. Providing an integrated 'one-stop-shop' service offering, from labelling and packaging to end-user distribution; our dedicated team of product supply managers ensure supply of your orphan / niche drug products from launch into commercial supply. Commercial Manufacture & Pack Commercial Manufacture of • Tablets • Capsules • Powders / granules Almac Pharma Services 2661 Audubon Road Audubon, PA 19403 Tel: 610 666 9500 Email: pharmaservices@almacgroup.com Website: www.almacgroup.com Corporate Description Services Recent Developments Almac Pharma Services Primary Packaging into • Blisters (thermoform & coldform) • Bottles, Jars, Tubs • Sachets Secondary Packaging into • Blister cards / Wallets • Cartons • Complex Kit Assembly Providing innovative solutions, we offer novel packaging capabilities such as multi-product blistering / packaging and online blister printing (both flexographic and digital). • $12m investment in a new US commercial packaging facility in Audubon, PA • Enhanced blistering capabilities at UK site for processing humidity sensitive drug products • Opening of new client dedicated sachet facility producing >250m sachets / annum at UK site Contact us today to discover how Almac's wide range of services and flexibility to handle projects of any size make us your preferred solid oral dose partner. Sourcebook_PBE-CCR 6/10/14 1:26 PM Page 6

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0614SB